Teotten Diagnostics Inc is categorized under Commercial Biotechnical Research in Durham, NC and active since 2004.
Teotten Diagnostics Inc was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 541711 by the NAICS.
If you are seeking more information, feel free to contact Jeffrey Shuster at the company’s single location by writing to 2 Davis Drive 14393, Durham, North Carolina NC 27709 or by phoning (919) 765-0037. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Teotten Diagnostics Inc |
| Contact Person: | Jeffrey Shuster |
| Address: | 2 Davis Drive 14393, Durham, North Carolina 27709 |
| Phone Number: | (919) 765-0037 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541711 |
| Share This Business: |
Teotten Diagnostics Inc was started in 2004 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 541711. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jeffrey Shuster for inquiries that concern Teotten Diagnostics Inc by calling the company number (919) 765-0037, as your correspondence is most welcome. Additionally, the physical location of the single location of Teotten Diagnostics Inc can be found at the coordinates as well as the street address 2 Davis Drive 14393 in Durham, North Carolina 27709.
For its online presence, you may visit Teotten Diagnostics Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.